Saturday, July 12, 2025

Latest

Mind Cure Receives Health Canada Approval For Sale Of Moonbeam Mushroom Products

Mind Cure Health (CSE: MCUR) has received the required authorizations from Health Canada for its functional mushroom products to begin to be sold within the country. The company has seen its branded Moonbeam Mushrooms products issued Natural Product Numbers the agency, enabling for the sale of the products at retailers.

The authorizations put the product line ahead of many competitors within the supplement and nutrition space whom often skip the task of receiving Health Canada compliance. Having the approval from the agency will provide additional transparency to consumers, while providing evidence that the products are in fact considered natural supplements.

The Moonbeam Mushrooms product line consists of three offerings, each of which is offered in the form of powder and capsules. The products are focused on different functional mushrooms, including Lion’s Mane, Reishi, and Turkey Tail. Further, they have been marked as being non-GMO, vegan, organic, free of soy as well as gluten. New product offerings from the firm are currently being investigated as well, in the fields of nootropics, psychoactive products and psychedelic substances.

A timeline for products to hit retailers was not provided.

Mind Cure Health last traded at $0.55 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

Mindcure Completes Beta Testing, Launches PsyCollage

Mind Cure Health (CSE: MCUR) has completed the beta testing phase for its proprietary bioinformatics...

Tuesday, February 16, 2021, 07:22:53 AM

Mind Cure Health Begins Research Into Psychedelic Compounds

Mind Cure Health (CSE: MCUR) has reached a milestone, with the company this morning announcing...

Tuesday, December 8, 2020, 08:04:33 AM

Mind Cure Closes $3.6 Million Oversubscribed Financing

Mind Cure Health (CSE: MCUR) reported midday today that it has closed its non-brokered private...

Thursday, November 19, 2020, 04:28:12 PM

Mind Cure To See Nootropics Sold Across North America Via Body Energy Club

Mind Cure Health (CSE: MCUR) this morning released further plans related to the launch of...

Thursday, December 31, 2020, 09:17:25 AM

Mind Cure Enters LOI To Acquire Ephiphany360 Digital Therapeutics Platform

Mind Cure Health (CSE: MCUR) is getting into the digital therapeutics space. The company announced...

Wednesday, October 21, 2020, 08:47:34 AM